Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fertiply is a multi-ingredient nutraceutical supplement developed and marketed by Jay Ell Healthcare, an Indian pharmaceutical company. It is specifically formulated to support reproductive health and fertility, primarily through its antioxidant and metabolic support properties. The formulation contains a combination of astaxanthin, coenzyme Q10 (CoQ10), levocarnitine (L-carnitine), lycopene, and zinc. These ingredients work synergistically to mitigate oxidative stress, which is a significant contributing factor to both male and female infertility. Coenzyme Q10 and levocarnitine specifically support mitochondrial function and cellular energy production, which are critical for gamete quality and motility. Fertiply is part of Jay Ell Healthcare's gynecological and fertility-focused product portfolio.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Fertiply.